Discover
CLYM
Climb Bio Inc
13.29
2 x 9.68
2 x 15.88
bid
ask
+
0.25
1.92%
2 @ 04:00 PM
13.29 +0.00 (0.00%)
| Ytd | 232.25% | |
| 1y | 1016.81% |
12.34
day range
13.59
1.19
52 week range
13.69
| Open | 12.89 | Prev Close | 13.04 | Low | 12.34 | High | 13.59 | Mkt Cap | 761.03M |
| Vol | 1.91M | Avg Vol | 1.10M | EPS | -0.77 | P/E | N/A | Forward P/E | N/A |
| Beta | -0.34 | Short Ratio | 15.74 | Inst. Own | 84.52% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 11.00 | 200-d Avg | 5.92 | 1yr Est | 10.00 |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|
Profile
Climb Bio, Inc., a biotechnology company, focuses on developing therapies for autoimmune-driven inflammatory diseases. It develops budoprutug, an anti-CD19 monoclonal antibody for various autoimmune diseases, including systemic lupus erythematosus and lupus nephritis, immune thrombocytopenia, and membranous nephropathy. The company was formerly known as Eliem Therapeutics, Inc. and changed its name to Climb Bio, Inc. in October 2024. Climb Bio, Inc. was incorporated in 2018 and is headquartered in Wilmington, Delaware.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2024-07-21 | MORISSET VALERIE | Officer | 31.32K | Sale |
| 2024-12-18 | PIMBLETT EMILY | Officer | 11.33K | Sale |
| 2024-06-26 | RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | 0.00 | Purchase |
| 2024-06-26 | THOMAS STEPHEN BASIL | Director | 103.91K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | RA Capital Management, L.P. | 31.42M | 60.32M | 46.74% |
| 2024-09-29 | Janus Henderson Group PLC | 3.61M | 6.92M | 5.36% |
| 2024-09-29 | Samsara BioCapital, LLC | 2.61M | 5.01M | 3.88% |
| 2024-09-29 | Boxer Capital, LLC | 2.60M | 5.00M | 3.87% |
| 2024-09-29 | Deep Track Capital, Lp | 2.17M | 4.16M | 3.23% |
| 2024-09-29 | Blackrock Inc. | 1.87M | 3.58M | 2.78% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 899.65K | 1.73M | 1.34% |
| 2024-10-30 | iShares Russell 2000 ETF | 723.54K | 1.39M | 1.08% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 404.12K | 775.91K | 0.60% |
| 2024-10-30 | iShares Russell 2000 Value ETF | 257.81K | 495.00K | 0.38% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 148.34K | 284.82K | 0.22% |
| 2024-08-30 | Fidelity Small Cap Index Fund | 73.99K | 142.05K | 0.11% |